PX-2
 | |
| Systematic (IUPAC) name | |
|---|---|
|
(R)-N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| ChemSpider | 32741702 |
| Chemical data | |
| Formula | C22H25FN4O2 |
| Molar mass | 396.47 g/mol |
| |
| |
PX-2 (also known as 5F-APP-PINACA and FU-PX) is an indazole-based synthetic cannabinoid that has been sold online as a designer drug.[1]
Legality
Sweden's public health agency suggested classifying PX-2 as hazardous substance on November 10, 2014.[2]
PX-2 is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[3]
As of October 2015 PX-2 is a controlled substance in China.[4]
See also
References
- ↑ "PX 2". Cayman Chemical. Retrieved 15 July 2015.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 16 July 2015.
- ↑ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 24 July 2015.
- ↑ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Friday, February 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.